A detailed clinical comparison of tretinoin topical and oral isotretinoin covering efficacy, cost, access requirements, side-effect profiles, and how to choose between them for acne and skin concerns.
A comparison of tretinoin and topical minoxidil, covering mechanisms, clinical evidence, and how to switch safely between them for skin and hair goals.
A clinical comparison of eszopiclone (Lunesta) and trazodone for insomnia, including the evidence base for combining them, pharmacology, switching protocols, and safety data prepared by the HealthRX.com Editorial Team.
A comparison of eszopiclone (Lunesta) and trazodone for insomnia, including how to switch between them, dosing, safety data, and which patients do better on each drug.
A clinical comparison of suvorexant (Belsomra) and lemborexant (Dayvigo) covering efficacy, safety, next-morning alertness, and a step-by-step protocol for switching between them.
Liraglutide and retatrutide: what studies show, whether switching or combining is established, and how product, access and population differences matter.
A detailed clinical comparison of oral estradiol and vaginal estradiol side-effect profiles, covering systemic absorption, VTE risk, breast tissue exposure, and when each route is the right choice for menopausal women.
A clinical comparison of estradiol patch versus oral estradiol covering pharmacokinetics, safety, cost, insurance coverage, and access, with primary-source citations throughout.
A clinical comparison of transdermal estradiol patch vs oral estradiol for menopausal HRT. Covers efficacy, VMS relief, cardiovascular risk, clot risk, bone protection, and how to choose.
A clinical comparison of oral micronized progesterone (Prometrium) and oral estradiol for menopausal HRT, covering endometrial protection, vasomotor symptom relief, cardiovascular effects, bone density, and safety profiles with trial data.
A detailed clinical comparison of oral micronized progesterone and Prometrium for women's HRT, including trial data, dosing, safety profiles, and when each is preferred.
A guide to stopping testosterone replacement therapy for male hypogonadism safely, including tapering protocols, HPG axis recovery, and monitoring schedules backed by Endocrine Society guidelines.
Perimenopause and menopause drive real psychiatric symptoms including depression, anxiety, and cognitive changes. Learn how to diagnose the overlap, which treatments work, and what major society guidelines recommend.
Evidence-based strategies to prevent the return of menopause symptoms, protect bone density, support cardiovascular health, and sustain quality of life. prepared by the HealthRX.com Editorial Team.
A clinician-grade, step-by-step guide to diagnosing metabolic syndrome using ATP III, IDF, and harmonized AHA/NHLBI criteria, plus evidence-based treatment pathways for all five components.
How partners and family members can support obesity treatment. Evidence-based strategies covering shared lifestyle change, emotional support, medication adherence, and what the guidelines say.
A clinical deep-dive into why Black, Hispanic, Native American, and Pacific Islander adults carry a disproportionate burden of obesity, what drives those gaps, and how current guidelines address them.
A complete walkthrough of the OSA diagnostic algorithm: screening tools, home vs. Lab sleep testing, AHI thresholds, severity classification, and first-line treatment options including CPAP, weight loss, and tirzepatide (Zepbound).
A guide for caregivers and family members supporting someone with PCOS. Covers diagnosis, treatment options, emotional support strategies, and when to seek specialist care.
PCOS is a hormonal and metabolic condition that affects an estimated 6-12% of reproductive-age women and is associated with a meaningfully higher rate of depression, anxiety, and disordered eating. This article explains the plausible mechanisms, how clinicians screen, what treatments have evidence behind them, and where the research is still incomplete.
An evidence-based PCOS treatment algorithm organized by line of therapy, covering lifestyle, metformin, combined oral contraceptives, letrozole, GLP-1 agonists, and surgical options with full citations.
A clinical guide to the conditions that commonly co-occur with perimenopause, including thyroid disease, metabolic syndrome, mood disorders, sleep disturbance, and cardiovascular risk, with guidance on what to screen for and when to escalate care.
A stage-by-stage guide to the real costs of perimenopause care, from early irregular cycles through late-stage vasomotor symptoms, including medication costs, lab work, and when to seek specialist care.
Learn how genetics and family history shape perimenopause timing, symptom severity, and treatment options. Evidence-based guidance from the HealthRX.com medical team, with citations to primary research.
1.1 mil millones de mujeres estarán en o tras la transición menopáusica para 2025, con 47 millones entrando en perimenopausia cada año.
How partners and family members can support someone through perimenopause, including symptom education, communication strategies, and when to encourage professional care.
A guideline-based treatment algorithm for perimenopause: first-line, second-line, and third-line options for vasomotor symptoms, cycle irregularity, mood disturbance, and bone protection, with dosing, evidence grades, and society recommendations.
Prediabetes and mental health disorders share overlapping biology, risk factors, and treatment gaps. Learn how depression, anxiety, and chronic stress drive glucose dysregulation, and what clinical guidelines say about screening and treating both.
A guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
A guide to exercise protocols for secondary hypogonadism, covering resistance training, HIIT, aerobic work, and how structured movement affects LH, FSH, and testosterone recovery.
An evidence-based treatment algorithm for tendinopathy covering first-line load management and eccentric exercise through third-line PRP, BPC-157, and surgical referral, with citations to primary RCTs and society guidelines.
A review of mechanistic research beyond LDL-lowering in established cardiovascular disease, covering inflammation, clonal hematopoiesis, gut microbiome signaling, Lp(a), and GLP-1 receptor agonists, with notes on evidence strength and what remains unproven.
How common is metabolic syndrome worldwide? Epidemiology data, regional breakdowns, rising trends, diagnostic criteria, and clinical guidance from primary sources.
Metabolic syndrome affects 1 in 3 U.S. Adults and generates hundreds of billions in annual healthcare costs. This guide covers the economic burden, racial and income disparities, productivity losses, and evidence-based interventions that reduce both health and financial harm.
A clinical history of NAFLD and MASLD treatment from the 1980s to today, covering lifestyle interventions, vitamin E, pioglitazone, and the first FDA-approved therapy resmetirom, with primary-source citations throughout.
A comprehensive clinical review of racial and ethnic disparities in NAFLD / MASLD prevalence, severity, genetics, and treatment access, with primary-source citations and guidance.
A deep dive into the latest OSA mechanism research: loop gain, arousal threshold, upper-airway muscle dysfunction, hypoxic signaling, and GLP-1 pathway discoveries that are reshaping treatment strategy.
A comprehensive clinical history of obstructive sleep apnea treatment from tracheotomy in the 1960s through CPAP, oral appliances, surgery, and the emerging GLP-1 era, with primary-source citations throughout.
Black, Hispanic, Asian, and Native American populations face higher OSA prevalence, later diagnosis, and worse outcomes than white patients. Learn what drives these gaps and what clinicians can do.
A look at the most contested questions in post-surgical recovery, from opioid-sparing protocols to optimal nutrition timing, with primary-source citations and practical guidance.
A clinical review of racial and ethnic disparities in post-surgical recovery, covering pain management, complication rates, readmission, and evidence-based strategies to close the gap.
A deep dive into the socioeconomic impact of post-surgical recovery, covering direct medical costs, lost productivity, caregiver burden, and disparities in recovery outcomes across income and insurance strata.
A clinically rigorous review of the most contested debates in prediabetes research: diagnostic thresholds, reversal definitions, treatment with metformin, overdiagnosis risk, and what current guidelines actually recommend.
A clinical deep-dive into how prediabetes treatment has evolved from lifestyle-only advice in the 1980s through modern pharmacotherapy and precision medicine, with primary-source citations and actionable guidance.
Why prediabetes rates differ sharply by race and ethnicity, which populations carry the highest burden, and what ADA and USPSTF guidelines recommend for equitable screening and treatment.
A review of the most contested clinical questions in tendinopathy management, from diagnosis and pathology staging to loading protocols, injections, biologics, and surgery thresholds, with an honest account of where the evidence is solid and where it is not.
An evidence-based review of the emerging biological mechanisms driving tendinopathy, including neurogenic inflammation, failed healing responses, metabolic drivers, and new therapeutic targets backed by primary-source research.
A clinical overview of the socioeconomic burden of tendinopathy, covering direct medical costs, productivity losses, disability rates, and evidence-based management strategies that reduce long-term expenses.
A comprehensive, evidence-based review of how race and ethnicity shape type 2 diabetes risk, diagnosis, complications, and treatment access, with primary-source citations throughout.
A clinically grounded review of the socioeconomic burden of type 2 diabetes, direct medical costs, lost productivity, racial and income disparities, and actionable strategies backed by primary trial and guideline data.
Does Farxiga (dapagliflozin) reduce appetite or change food cravings? A PharmD/MD-level review of the mechanisms, clinical trial data, and what patients can realistically expect.
A clinical deep-dive into how dapagliflozin (Farxiga) affects mental health, mood, depression risk, and quality of life. Covers DAPA-HF, DAPA-CKD, and emerging mechanistic data with physician-level citations.
A clinician-level review of how dapagliflozin (Farxiga) affects sleep architecture, nocturia, OSA-related outcomes, and cardiorespiratory physiology, with primary-literature citations.
A deep-dive into denosumab (Prolia) and cognition: RANKL biology, FREEDOM trial data, pharmacovigilance signals, and clinical decision-making for patients concerned about brain fog or cognitive decline.
A comprehensive clinical guide to the denosumab pre-surgery hold window, covering fracture rebound risk, optimal timing, bridging strategies, and evidence-based protocols for perioperative management of Prolia patients.
Randomized trials from 2011-2015 show myo-inositol restores ovulation in up to 62% of PCOS patients versus 27% on placebo, rivaling metformin.
A deep dive into the bidirectional relationship between chronic low-grade inflammation, weight gain, insulin resistance, and metabolic disease, with specific clinical data, named trials, and actionable guidance.
Board-reviewed guide covering daily fiber targets by age and sex, the difference between soluble and insoluble fiber, blood sugar effects, and practical food sources with serving sizes.
GLP-1 receptor agonists drive significant weight loss, but up to 40% of that lost weight can be lean mass. This evidence-based guide covers protein targets, resistance training protocols, and clinical strategies to protect muscle while on semaglutide or tirzepatide.
A complete guide to PCOS diagnosis: which blood tests, imaging, and clinical criteria doctors use, what normal and abnormal results mean, and how to prepare for each step.